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Comparing effectiveness of two client follow-up
approaches in sustaining the use of Long Acting
Reversible Contraceptives (LARC) among the
underserved in rural Punjab, Pakistan: a study
protocol and participants’ profile
Syed Khurram Azmat1,2, Waqas Hameed2, Moazzam Ali3*, Muhammad Ishaque2, Ghulam Mustafa2,
Omar Farooq Khan2, Ghazunfer Abbas2 and Erik Munroe4

Abstract
Background: Pakistan observes a very high i.e. 37 percent modern contraceptive method related discontinuation
rates within 12 months of their initiation. And almost 10 percent of these episodes of discontinuation happened
due to the side effects or health concerns experienced by the women. Most importantly, it was noted that more
than 12,000 first-level care facilities are located in the rural areas, including rural health centers, basic health units,
and family welfare centers, but more than 30% of these facilities are nonfunctional. This paper presents a study
protocol and participants’ profiling of a prospective cohort follow-up to compare the effectiveness of household
based and telephonic approaches in sustaining the use of Long Acting Reversible Contraceptives (LARC) whilst to
facilitate lowering method related discontinuation and increasing switching amongst the contraceptive users.
Methods: A 12-month multi-centre, non-inferiority prospective user follow-up is employed using three different
study categories: a) household based follow-up; b) telephonic follow-up; and c) passive or need-based follow-up
along with the hypothetical assumption that the telephonic client follow-up is not inferior to the household based
follow-up by continuation rate of LARC and the telephonic follow-up is less-costly than the household based client
follow-up. This follow-up will be conducted in 22 health facilities – (16 rural and 6 urban based facilities) in district
Chakwal. The first two study categories will receive scheduled but different follow-up from the field workers at 1, 3,
6, 9, and 12 month while the third one i.e. the ‘passive or need-based follow-up’ will serve as a control group. Using
sampling software PASS 11, it was estimated to have 414 clients in each study category and around 1366 clients will
be recruited to account for 10% attrition rate.
Discussion: The study will help us to examine a more convenient method of effective follow-up for managing side
effects, decreasing method discontinuation and increasing switching amongst users. The study information will also
facilitate to develop a robust, effective and efficient mechanism for client follow-up to promote the continuation
rates of LARC methods. The follow-up results and lessons learnt will be widely shared with stakeholders for their
implementation and streamlining in health system.
Keywords: Family planning, Long acting reversible contraceptives, Method discontinuation, Non-inferiority
prospective client follow-up, Maternal health, Study protocol, Punjab, Pakistan
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Background and context
Family planning (FP) is considered as one of the most
cost effective interventions and has an imperative function to reduce maternal, infant and child health related
morbidity and mortalities - as such that it has the potential to prevent around 30% of maternal deaths and 10%
of child deaths [1,2]. But the benefits of family planning
are not limited just to promoting maternal or child
health but can significantly influence enhanced opportunities for higher socioeconomic status, education,
employment and empowerment especially for girls and
women [3]. Likewise, family planning/contraception use
also reduces the rates of unskilled unsafe abortions by
preventing the mistimed or unwanted pregnancies [2].
But unfortunately, almost 300,000 women died only in
2013 due to pregnancy related complications which were
avoidable [4,5] and the preventable causes such as
hemorrhage, hypertension and infections accounted for
56.8% of all maternal deaths [6]. It was noted that in the
absence of contraceptive use, these deaths are projected
to be almost two-fold higher [7].
In Pakistan, the lifetime risk of maternal death is one
in 170 for women [8], and Pakistan is one of the six
countries in the world anticipated to contribute to over
half of all maternal deaths and complications of pregnancy and childbirth remain the leading cause of death
and disability for childbearing women in Pakistan [9].
During the past 22 years, there is a three-fold progressive but gradual increase in the contraceptive use in
Pakistan i.e. from 12 percent in 1990–91 to 30 percent
in 2006–07 and then to 35 percent in 2012-13 [10,11].
Likewise, the unmet need for family planning decreased
from 31 percent to 20 percent during this period. But
very unfortunately, modern contraceptive use remain as
low as at 26 percent in contrast to the extremely high
and favorable universal knowledge of contraception (almost 99%) with more dependency on short term, traditional and permanent methods of contraception [10].
Most importantly, the use of highly effective long acting
reversible contraceptives (LARC) such as IUD and implant has remained almost negligible for a decade [1,12].
The country also observes high contraceptive discontinuation rates of 37 percent within 12 months of their initiation resulting in particular from the side effects or
health concerns associated mainly with short term modern
contraceptives such as injections, pills and condoms [10].
In Pakistan, in a recent retrospective study in 2011 the
contraceptive users revealed high IUD discontinuation
among users (16.3% at 12 months) [13] while the implant 1-year discontinuation stands at 10% [14]. Importantly, the recent demographic survey reported a very
high 26% of IUD discontinuation rate at 12 month.
However, the main reason cited for IUD discontinuation
was side effects in almost all the cases [10,13,14].
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To promote modern family planning methods especially LARC methods, Marie Stopes Society (MSS), a
local non-governmental organization in Pakistan, implemented a research project titled “Meeting the birth spacing needs of the underserved in Punjab province in
Pakistan” and used demand-side financing – (DSF)
through vouchers and expanding the Suraj health providers model (a Social Franchise (SF) network of health
providers) as a two-pronged approach in order to increase the use and uptake of modern contraceptives
[15]. Earlier evidence suggests that the DSF vouchers
and social franchising; as an integrated approach used
for LARC choices, has the potential to increase awareness and use of LARC methods [16,17].
In the MSS Pakistan implemented research project titled “Meeting the birth spacing needs of the underserved in Punjab Province in Pakistan” the Field Health
Educators (FHE) are working as a Community Health
Worker within the Suraj model and has a similar role
to a Lady Health Worker – LHW (LHW Programme is
a Government of Pakistan owned Primary Health Care
Initiative) and covers a population of around 20,000 to
25,000 spread over 3 – 6 kilometer radius [15]. This
population catchment is far higher compared with the
population and catchment areas of LHWs and Community Midwives – CMWs (CMW programme is a Maternal,
Newborn and Child Health Initiative of the Government
of Pakistan mainly for the population residing in the
most far-flung rural areas) [15]. Each LHW serves a
population of 1,000 people in their rural community
while one CMW stationed for 5000 - 10,000 populations
[15,18-20]. This makes it challenging for FHE to frequently pay household based follow-up visits to the
clients.
A large number of systematic reviews have documented the important role of community-based interventions including the household-based visits by
community health workers to improve maternal and
newborn health outcomes [21]. Likewise, several studies
have cited that by strengthening the counseling and
follow-up services component of the family planning
programs will support women’s continuation of effective
methods and ensure higher quality of services [22-24].
For example, a pool of studies have attempted to measure the effects of different approaches of user follow-up
such as an scheduled visit at the clinic or a follow-up
telephone contact and have reported mixed results; however, these studies has design and quality limitations
[25]. Another study identified the importance of followup at six weeks for detecting early expulsion but the
same study did not found any significant association between the regular visits and fewer pregnancies or expulsions [26]. Amongst those who cited medical reasons for
the removal of IUD, there was a significant difference
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between the more frequent follow-up users as compared
to the fewer scheduled follow-up as the earlier had a
longer period of IUD continuation [26]. However, effect
of a follow-up telephone call was not found as significantly different [27-30]. Unfortunately, sparse evidence
is available on utility of household or telephone based
client follow-up for family planning in Pakistan and in
the neighboring countries.
Thus, there is a need to study effects of prospective
follow-up to the end-user and counseling related to
side-effect management by a provider or community
health worker in the rural setting in Pakistan. Therefore,
we propose to conduct a prospective cohort follow-up
to compare the effectiveness of household based and
telephonic approaches in sustaining the use of LARC
among SF clients. Very recently, the Department of Reproductive Health and Research at the World Health
Organization in Geneva unveiled the 15 highest priority
topics as their global agenda to promote family planning
research [2]. Amongst those identifying main barriers to
the uptake and use of modern contraceptive in low
prevalence settings and the determinants of the discontinuation as well as switching of contraceptive methods
seem extremely relevant and timely for our study [2]. In
addition, engagement with the private sector through
franchising; task shifting and impact of financing schemes
on quality are also pertinent for our study [2].
Following are research questions, hypothesis and list
of measurement indicators of the proposed study:
Research Question
1. Is telephonic client follow-up on LARC continuation
is as effective as the effect of (gold standard) active
household based client follow-up?
2. Is the telephonic client follow-up less costly compared
with the household based client follow-up?
Hypothesis
1. The telephonic client follow-up is not inferior to the
household based follow-up by continuation rate of
LARC.
2. The telephonic client follow-up is less-costly than
the household client follow-up.
List of follow-up measurement indicators
1. The cumulative probability of LARC discontinuation
1, 3, 6, 9, and 12 months by study arms.
2. The reasons for LARC discontinuation
3. Level of client satisfaction with the counseling
received from FHE by study arms
4. The proportion of clients lost to follow-up
5. Cost per telephonic call and per household based
visit
6. Time duration per call
7. Level of difficulty faced by client in contacting FHE
by follow-up group
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Methodology
The present study is nested in the larger research project Meeting the birth spacing needs of the underserved in
Punjab Province in Pakistan [15].
Design

A multi-centre, prospective non-inferiority trial.
Scope

This 12 month follow-up from December 2013 – December
2014 will be conducted only in Chakwal district nested
under the routine monitoring of programme activities on
Demand Side Financing [15]. A total of 22 centers will be
included in this follow-up, of which 16 are mid-level providers branded as Suraj (i.e. in English, called Sun, is a
brand provided to the clinics of the trained providers of
MSS) and located in rural periphery, while the 6 are medical doctors based in peri-urban or urban areas.
Follow-up cohorts

The recruitment of follow-up participants will take place
under three different categories: a) household based
follow-up; b) telephonic follow-up; and c) passive or
need-based follow-up, serving as control group. The clients recruited under category ‘a’ will receive a scheduled
follow-up from FHE at 1, 3, 6, 9, and 12 month. Similarly, the clients recruited under category ‘b’ will receive
a telephone call from FHE at the scheduled frequency
similar to category ‘a’. In addition, the participants of
both the categories (‘a’ & ‘b’) can also seek medical advice from FHE based on need (unscheduled contact).
While, category ‘c’ participants will not receive any
scheduled intervention from FHE but can only seek
FHE’s assistance in case of any medical need.
Sample size

In order to detect 6% difference amongst the categories,
with an 80% power and using sampling software PASS
11, it was estimated to have 414 clients in each of the
three groups. Around 1366 clients will be recruited to
account for 10% attrition rate. Based on services statistics the estimated sample can be achieved if all the clients at each clinic (who gives informed consent) are
registered during the (specified) period for 3-4 months.
Thereby clinics having high clientele will contribute more
to the sample (to hold proportionality assumption).
Sampling strategy

Based on preliminary data taken from the field, it is estimated that around 40% of the LARC users have mobile
phones [31] thus due to shorter recruitment time, selection of follow-up participants will be done following
consecutive sampling. The reason for selecting consecutive sampling over randomization was mainly the long
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recruitment periods and the budgetary implications.
After screening, all the clients receiving LARC during 34 months (Nov 2013 till Feb 2014) period will be briefed
about follow-up and invited to participate in the followup based on their informed consent. Clients will be
asked to voluntarily choose the group (among the three
described above) under which she would like to be enrolled. Once the desired sample of any specific group is
achieved, that group will be eliminated as an option for
subsequent clients to opt for. A format will be given to
each service provider to keep a track of client enrollment under each group. The same information shall be
recorded on the baseline and follow-up form so as to ascertain the selection is performed as per the protocol.
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in all of the categories were of twenty years of age or less
at the time of their marriage and the average age of husbands for majority was between 30 and 40 years range
for all categories.
Majority of the women in all three categories had no
formal education (observed as 36.3%, 40.8% and 43.2% for
Telephone, Physical and Passive categories respectively).
Moreover the ‘type of client’ indicator showed that majority i.e. Telephone (95%), Physical (90.2%) and Passive
(91.6%) obtained their FP services via vouchers. The percentage for IUCD uptake was 78.5%, 85.3% and 85% for
Telephone, Physical and Passive categories respectively.
The majority of all three categories showed a favorable
view of the husband with regards to using a contraceptive method (refer to Table 2).

Tool

A structured questionnaire at baseline and 12-month
will be administered to document socio-demographic
characteristics and user-related reasons (decision making, acceptability, costs, convenience of method type,
timing) and health-related reasons reported by the
women. The questionnaire was developed by MSS and
reviewed by Department of Reproductive Health and Research, WHO. Moreover, all the enumerators will be
given thorough training on all the questionnaires.
Implementation

Once the client adopted the LARC, she will be asked to
participate in the follow-up. As described above, the
women enrolled under the active categories (‘a’ & ‘b’)
will receive counseling on side-effect management,
through an adapted manual used in the Family Advancement for Life and Health (FALAH) project [32] at 1, 3,
6, 9 and 12-month post IUCD insertion. The FALAH
was a family planning project supported by the United
States Agency for International Development (USAID)
whose aim was to protect the health and well being of
mothers, newborns and children through the adoption
of birth spacing by eligible couples in Pakistan [33]. The
same manual will be used to assist women with sideeffect management as per need. In order to minimize
dropouts/lost-to-follow-up, all the clients will be informed about the detailed follow-up procedures, while
taking informed consent. For schedule visits, the FHEs
will be reimbursed for their transportation cost. Similarly, FHEs will also be paid for telephone call expenses.

Baseline information
Socio-demographic characteristics and participants’ profile

The socioeconomic profile had N = 424, 409 and 428
women for the Telephone, Physical and Passive followup categories respectively (refer to Table 1). All three
categories showed the largest number of women in the
age group of 24 to 35 years of age. Most of the women

Reproductive health and contraceptive history

Reproductive health and contraceptive history show that
most of the women in each group had 3-4 pregnancies
and also had similar number of living children as well
(Refer to Table 3).
The percentage of women who did not use any contraception in the past three months was 44% in each Telephone, Physical and Passive categories (Table 3). When
questioned about ‘spacing’ with regards to the ‘desire to
have more children’; many women expressed for a desired spacing period of 36 months before their next
child.
Information pertaining to IUCD/Implant services

Long acting effectiveness was the main reason for choosing IUCD/Implant among Telephone (61.3%), Physical
(59.2%) and Passive (55.3%) categories. Similarly the decision to take up the service was made mostly by the
women themselves in all three categories; while mutual
decision by husband and wife was identified as second
most common factor (refer to Table 4). It was noted that
the majority of the participants (more than 75%) reported having no side effects during ICUD/implant insertion amongst all categories. Likewise, most of the
women (more than 65%) didn’t get any painkillers to
take home after the insertions.
Counseling and quality of information provided

The majority of the clients reported that they received
counseling on all family planning methods before they
opted for IUD or Implant (refer to Table 5). As shown in
Table 5, most of the women in Telephone (89%), Physical (91%) and Passive follow up (92%) categories got
clear instructions in case they experience any side effects. Similarly, majority of the women among all categories got the method of their choice.
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Table 1 Socio-demographic characteristics and
participant’s profile by prospective client follow-up group*
Indicators

Telephone
group

Physical
group

Passive
group

N = 424

N = 409

N = 428

%

%

%

15 – ≤ 24

10.4

7.8

8.2

>24 – ≤ 34

66.7

63.3

60.5

≥35

22.9

28.9

Average (S.D)

30.4 (4.7)

31.0 (4.9)

P-value

0.06
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Table 1 Socio-demographic characteristics and
participant’s profile by prospective client follow-up group*
(Continued)
Husband occupation
Unskilled manual

18.4

21.8

22.9

Skilled manual

21.9

21.5

21.7

Agriculture/Farming

11.3

16.6

17.3

Sales & services

17.0

14.9

13.8

31.3

Professional/Technical
manager

17.5

12.7

13.3

31.0 (5.2)

Clerical/Office work

7.5

5.9

5.1

Household chores

2.6

1.5

1.9

Jobless

3.8

5.1

4.0

0.20

Age of women

Age of women at time of marriage
≤20

62.0

63.8

62.6

P-value

>20 – ≤ 25

31.1

28.9

29.0

Family monthly income (PKR) (1 USD = 102 PKR)1

>25

6.8

7.3

8.4

≤5,000 (49 USD)

13.6

13.8

14.2

Average (S.D)

20.3 (3.1)

20.3 (3.1)

20.6 (3.2)

55.1

58.8

52.8

P-value

0.86

>5,000 – ≤10,000
(>49 USD – 98)
>10,000 – ≤15,000
(>98 USD – 147)

22.9

20.0

19.3

>15,000 (>147 USD)

8.4

7.4

13.6

Average (S.D)

10,282 (7654)

10,263 (9,149) 10,433 (5,166)

100.8 USD (75) 100.6 (89.7)

102.3 (50.7)

Median

9,000

9,000

9,000

88.2 USD

88.2 USD

88.2 USD

P-value

0.12

Age of husband
≤30

23.1

17.4

20.6

>30 – < 40

46.7

47.2

41.6

≥40

30.2

35.5

37.9

P-value

0.06

Women education
No formal education

36.3

40.8

43.2

Can read/write

4.7

3.2

2.6

Primary

12.0

15.9

13.1

9.8

8.4

11.1

15.6

12.4

Out of Pocket
(referred by FHE)

5.0

Middle
Secondary

25.7

17.4

19.4

Voucher

95.0

90.2

91.6

Intermediate

6.1

4.9

5.1

P-value

0.03*

Graduate/Post Graduate 4.0

2.2

4.2

Type of Provider

P-value

0.03*

Working women

Type of client

Suraj SF (Rural)

67.0

68.7

69.6

Urban Provider (Urban)

33.0

31.3

30.4

0.70

Yes

9.7

8.6

6.8

P-value

Housewife

90.3

91.4

93.2

FP method taken

P-value

0.30

Husband education

IUD

78.5

85.3

85.0

Implant

21.5

14.7

15.0

0.01*

No formal education

15.6

15.2

20.1

P-value

Can read/write

2.4

2.9

0.5

Primary

7.8

10.8

9.6

Middle

19.1

19.6

17.1

*Groups: Telephone group will receive a telephone call at the scheduled
frequency; Physical group will receive household based follow-up, and Passive
group category participants will not receive any scheduled intervention but
can only seek assistance in case of any medical need.
1
http://www.forex.pk/open_market_rates.asp.

Secondary

42.2

42.8

43.9

Intermediate

8.5

6.4

4.4

Graduate/Post Graduate 4.5

2.4

4.4

P-value

0.03*

Discussion
Based on the results of the study, we hope to identify a
more convenient method of effective follow-up for managing side effects, health concerns and other potential
reasons of method discontinuation and switching. The
study information will also facilitate to develop a robust,
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Table 2 Family views regarding FP contraceptive by
prospective client follow-up group
Indicators

Table 4 Reason and final decision making regarding
insertion of IUCD/Implant by prospective client follow-up
group

Telephone
group

Physical
group

Passive
group

N = 424

N = 409

N = 428

Telephone
group

%

%

%

N = 424

N = 409

N = 428

%

%

%

Indicators

Husband’s view on couple using a contraceptive method

Physical
group

Passive
group

Favors

81.7

71.8

74.3

Reason for choosing IUCD/Implant

Dislikes

8.3

15.9

13.9

Suggested by FHE (Suraj)

7.9

8.3

9.6

Don’t know/unsure

10.0

12.3

11.8

Suggested by FHE (Urban)

7.4

8.8

8.2

Suggested by Suraj client

4.1

4.6

1.6

Husband knows you have inserted IUCD/Implant

Long acting effectiveness

61.3

59.2

55.3

Yes

83.3

76.3

72.2

Freely available

7.2

7.6

7.7

No

16.7

23.7

27.8

Easily accessible

8.6

7.3

13.1

Others (fewer side effects,
suggested by husband/
LHW/Urban happy client)

3.5

4.1

4.4

0.14
62.3

64.6

P-value

P-value

<0.01

<0.001

Mother in law knows you have inserted IUCD/Implant
Yes

51.4

46.5

40.7

P-value

No

48.6

53.5

59.3

Final decision made by

P-value

<0.01

Myself

effective and efficient mechanism for client follow-up in
Suraj Social Franchise model for FHEs to promote the
continuation rates of LARC methods. The follow-up results and lessons learnt will be widely shared with stakeholders (both amongst government and private sector)

57.5

Husband

1.4

0.0

0.0

Both (husband & wife)

36.3

32.8

32.8

Mother in law

0.9

0.7

0.5

All together

3.8

1.9

1.9

P-value

0.08

Experienced side effects during IUCD/Implant insertion

Table 3 Reproductive health and contraceptive history by
prospective client follow-up group
Indicators

Yes

21.9

24.4

21.5

No

78.1

75.6

78.5

P-value

0.71

Telephone
group

Physical
group

Passive
group

N = 424

N = 409

N = 428

Got the painkillers to take home

%

%

%

Yes

32.9

38.4

32.6

No

67.1

61.7

67.4

P-value

0.35

Number of pregnancies
1–2

32.5

27.4

27.8

3–4

44.1

45.7

47.0

5 or more

23.3

26.9

25.2

Average (SD)

3.5 (1.8)

3.7 (1.8)

3.6 (1.8)

P-value

0.43

Number of living children
0–2

38.0

32.0

34.1

3–4

44.8

49.4

49.8

5 or more

17.2

18.6

16.1

Average (S.D)

3.1 (1.6)

3.3 (1.5)

3.2 (1.5)

P-value

0.37

Result of last pregnancy
Live birth

93.9

91.9

90.0

Still birth

3.8

5.1

5.4

Miscarriage/aborted

2.4

2.9

4.7

P-value

0.25

for their replication in health system. We will also use
the follow-up findings to contribute to the knowledge
base through publications in peer reviewed journals,
working paper series and relevant international/regional
conferences.
Depending on the results it is anticipated that we will
have relatively efficient, easy and less tiring (less mobility) approach to ensure post-method uptake follow-up.
This will also provide supportive environment in managing post-insertion follow-up for LARC users in the
rural areas in order to reduce higher method discontinuation and switching. We hope study findings will
help large cadre of LHWs and other outreach workers
to effectively follow-up clients and eventually leading
to reduction in contraceptive discontinuation in the
country.
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Table 5 Receive counseling on FP method before IUCD/
Implant insertion by prospective client follow-up group
Indicators

Telephone
group

Physical
group

Passive
group

N = 424

N = 409

N = 428

%

%

%

11.0

7.7

75.1

74.8

78.7

80.6

80.0

84.3

83.6

87.9

70.9

70.1

23.0

19.4

14.4

10.3

5.9

5.6

9.3

8.9

7.8

6.5

Contraceptive method (multiple responses)
None/Didn’t discuss any method

6.1

P-Value

0.03

Condoms

80.7

P-Value

0.07

Pills

84.0

P-Value

0.15

Injections

85.8

P-Value

0.06

IUCD

89.6

P-Value

0.03

Implant

72.2

P-Value

0.80

Female sterilization

17.0

P-Value

0.09

Male sterilization

9.4

P-Value

0.05

Withdrawal

4.5

P-Value

0.64

Periodic abstinence

7.3

P-Value

0.55

Emergency contraception

8.5

P-Value

0.55

Technical support
The role of the Department of Reproductive Health and
Research (RHR) at WHO is to provide technical advisory
support to the in-country project team/Principal Investigator (PI). This is not just limited to supervising the
Monitoring and Evaluation (M&E) aspect of the study,
but also to review and share continuous feedback on the
project activities and to create an enabling environment
for informed decision-making on operational issues,
research and policy or strategy. Moreover, multiple peerreviewed publications in professional international journals, best practices, case studies, conference presentations
and policy briefs will be produced through a consultative
process that involves the RHR technical adviser and the
study PI/project team.
Ethical considerations
The study protocol of the research project has received
approval by Research Ethics Committee of the National
Bioethics Committee (Ref: No. 4-87/12/NBC-92/RDC/

3548) and it is already published in the journal Reproductive Health (http://www.reproductive-health-journal.
com/content/11/1/39) [15,31]. Written informed consent will be taken from all survey participants in a manner that is appropriate for the local language, literacy
level and comprehension level of the target population.
Every respondent, irrespective of whether information is
being elicited using quantitative methods, will be informed about the nature and objectives of the project,
any real or perceived benefits or risks, and assurances of
confidentiality. All respondents have the right to refuse
to answer any question posed by the interviewer, and
that s/he may also stop the interview at any time and
there are no financial incentives for the participation in
the study. Moreover, no personal identifying information
will be recorded on questionnaires that can be used to
link recorded information to a specific individual. Steps
will also be taken to ensure privacy during interviews.

Potential risks
There will be no potential risks to the participants whilst
participating in the study except some loss of confidentiality which might occur during the study. To minimize
this, training will be provided to the study staff to ensure
and minimize breach of confidentiality of participants.
Participants’ contact information and informed consent
documents with participants’ names will be stored separately in lockers. No personal identifiers for participants
will appear on any data or documentation sent to the
funding organization. Participants will not be identified
by name in any report or publication resulting from the
study data.
Limitations
The follow-up will assess early discontinuation up to
12 months. There may be likely chance of some recall
bias in exact date/timing of discontinuation as the data
will be collected immediately after the last (12-month)
follow-up visit. Providers’ bias is also expected for specific
FP methods, furthermore due to non-randomization, clients’ observed and unobserved characteristics may confound the results.
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